PHIA Stock Overview
Koninklijke Philips N.V. operates as a health technology company in North America and internationally.
Koninklijke Philips Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€30.08|
|52 Week High||€50.98|
|52 Week Low||€28.18|
|1 Month Change||-4.08%|
|3 Month Change||-19.24%|
|1 Year Change||-33.18%|
|3 Year Change||-2.28%|
|5 Year Change||9.90%|
|Change since IPO||490.62%|
Recent News & Updates
Is Koninklijke Philips (AMS:PHIA) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
|PHIA||NL Medical Equipment||NL Market|
Return vs Industry: PHIA underperformed the Dutch Medical Equipment industry which returned 8.5% over the past year.
Return vs Market: PHIA underperformed the Dutch Market which returned 15.8% over the past year.
|PHIA Average Weekly Movement||6.5%|
|Medical Equipment Industry Average Movement||6.7%|
|Market Average Movement||4.4%|
|10% most volatile stocks in NL Market||7.2%|
|10% least volatile stocks in NL Market||2.6%|
Stable Share Price: PHIA is more volatile than 75% of Dutch stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: PHIA's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Dutch stocks.
About the Company
|1891||77,084||Frans van Houten||https://www.philips.com|
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components, as well as integrated clinical solutions; integrated interventional systems; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.
Koninklijke Philips Fundamentals Summary
|PHIA fundamental statistics|
Is PHIA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|PHIA income statement (TTM)|
|Cost of Revenue||€10.93b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
Jan 24, 2022
|Earnings per share (EPS)||1.37|
|Net Profit Margin||5.96%|
How did PHIA perform over the long term?See historical performance and comparison
2.8%Current Dividend Yield
Is Koninklijke Philips undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PHIA (€30.08) is trading below our estimate of fair value (€94.41)
Significantly Below Fair Value: PHIA is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: PHIA is good value based on its PE Ratio (22x) compared to the European Medical Equipment industry average (32.2x).
PE vs Market: PHIA is poor value based on its PE Ratio (22x) compared to the Dutch market (21.5x).
Price to Earnings Growth Ratio
PEG Ratio: PHIA's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: PHIA is good value based on its PB Ratio (2.2x) compared to the XE Medical Equipment industry average (4.6x).
How is Koninklijke Philips forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PHIA's earnings are forecast to decline over the next 3 years (-7.2% per year).
Earnings vs Market: PHIA's earnings are forecast to decline over the next 3 years (-7.2% per year).
High Growth Earnings: PHIA's earnings are forecast to decline over the next 3 years.
Revenue vs Market: PHIA's revenue (5.3% per year) is forecast to grow slower than the Dutch market (8.8% per year).
High Growth Revenue: PHIA's revenue (5.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PHIA's Return on Equity is forecast to be low in 3 years time (13.6%).
How has Koninklijke Philips performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PHIA has high quality earnings.
Growing Profit Margin: PHIA's current net profit margins (6%) are higher than last year (5.9%).
Past Earnings Growth Analysis
Earnings Trend: PHIA's earnings have grown by 9.8% per year over the past 5 years.
Accelerating Growth: PHIA's earnings growth over the past year (2.7%) is below its 5-year average (9.8% per year).
Earnings vs Industry: PHIA earnings growth over the past year (2.7%) underperformed the Medical Equipment industry 62.2%.
Return on Equity
High ROE: PHIA's Return on Equity (9.9%) is considered low.
How is Koninklijke Philips's financial position?
Financial Position Analysis
Short Term Liabilities: PHIA's short term assets (€9.4B) exceed its short term liabilities (€8.8B).
Long Term Liabilities: PHIA's short term assets (€9.4B) exceed its long term liabilities (€8.2B).
Debt to Equity History and Analysis
Debt Level: PHIA's net debt to equity ratio (57%) is considered high.
Reducing Debt: PHIA's debt to equity ratio has increased from 44.3% to 65.3% over the past 5 years.
Debt Coverage: PHIA's debt is well covered by operating cash flow (35.4%).
Interest Coverage: PHIA's interest payments on its debt are well covered by EBIT (12.2x coverage).
What is Koninklijke Philips's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: PHIA's dividend (2.83%) is higher than the bottom 25% of dividend payers in the Dutch market (1.55%).
High Dividend: PHIA's dividend (2.83%) is low compared to the top 25% of dividend payers in the Dutch market (4.19%).
Stability and Growth of Payments
Stable Dividend: PHIA's dividend payments have been volatile in the past 10 years.
Growing Dividend: PHIA's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (65.8%), PHIA's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: PHIA's dividends in 3 years are forecast to be well covered by earnings (45.6% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Frans van Houten (61 yo)
Mr. François Adrianus van Houten, also known as Frans, has been the Chief Executive Officer and Chairman of Management Board of Royal Philips at Philips India Limited since April 2011. Mr. van Houten serve...
CEO Compensation Analysis
Compensation vs Market: Frans's total compensation ($USD7.03M) is above average for companies of similar size in the Dutch market ($USD3.01M).
Compensation vs Earnings: Frans's compensation has been consistent with company performance over the past year.
Experienced Management: PHIA's management team is seasoned and experienced (6 years average tenure).
Experienced Board: PHIA's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Koninklijke Philips N.V.'s employee growth, exchange listings and data sources
- Name: Koninklijke Philips N.V.
- Ticker: PHIA
- Exchange: ENXTAM
- Founded: 1891
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: €25.766b
- Shares outstanding: 856.72m
- Website: https://www.philips.com
Number of Employees
- Koninklijke Philips N.V.
- Philips Center
- Amstelplein 2
- 1096 BC
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/16 19:05|
|End of Day Share Price||2022/01/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.